Seoul, South Korea

Mee-Hyang Kweon

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Phyto Corporation Limited. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mee-Hyang Kweon. Retrieved from https://idiyas.com/inventor/mee-hyang-kweon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Mee-Hyang Kweon

Introduction: Inventor Mee-Hyang Kweon, a distinguished male innovator from Seoul, South Korea, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Mee-Hyang Kweon holds several recent patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights: With a career spanning over two decades, Mee-Hyang Kweon has worked with leading research institutions and technology companies, honing his skills and expertise in developing cutting-edge solutions to complex challenges.

Collaborations: Throughout his career, Mee-Hyang Kweon has collaborated with top universities, multinational corporations, and fellow inventors, fostering a culture of innovation and knowledge-sharing within the industry.

Conclusion: Inventor Mee-Hyang Kweon's passion for pushing the boundaries of technology and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in the global innovation landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…